TABOO Review by John Pinching. At the dawn of modern medicine, a collective of healthcare gurus agreed that a civilised world deserved a formalised and scientific approach to maki ...
Digital dexterity and robust site relationships – skills for today’s CRAs ...
The recognition of PED as a metric of therapeutic value and the growing role of this data in decision-making during ...
NHS – gifts and mixed blessings for pharma ...
The Health Service Executive (HSE) has approved BIMZELEX (bimekizumab) in Ireland for adults living with moderate-to-severe ...
Merck Sharp & Dohme (MSD) has agreed to acquire Cidara Therapeutics in a transaction valued at approximately $9.2 billion, ...
Xmoor Pharma and Royal Free London NHS Foundation Trust have announced a strategic collaboration to create a seamless pathway ...
The Cognitive Function Test, developed by experts at the Food for the Brain Foundation, has already been taken by more than 200,000 people. The charity, the only one in the UK focussing primarily on ...
The bells are ringing out for another spectacular Christmas edition of PharmaTimes. This year, we recline and reflect on a ...
The National Institute for Health and Care Excellence (NICE) has issued final draft guidance recommending Amvuttra ...
The approvals represent the first PD-1 inhibitor plus ADC regimens for this patient population. Treatment involves Keytruda or Keytruda Qlex with Padcev before surgery and continued after cystectomy.
The Academy of Medical Sciences and Wellcome have announced a new five-year agreement worth £27.3 million, reinforcing their ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback